Showing results (81-90 of 95) with videos related to
Sort By:
Pageof 10
American Journal of Obstetrics and Gynecology|April 16, 1998
The one-year morphometric and neurodevelopmental outcome of the offspring of women who continued to exercise regularly throughout pregnancyJ F Clapp, S Simonian, B Lopez, et al.American Journal of Obstetrics and Gynecology|April 15, 1980
Physiologic variability and fetal electrocortical activityJ F Clapp, H H Szeto, R Abrams, et al.Placenta|March 1, 1995
The effects of maternal aerobic exercise on human placental development: placental volumetric composition and surface areasM R Jackson, P Gott, S J Lye, et al.American Journal of Obstetrics and Gynecology|September 1, 1982
The ovine fetoplacental endocrine response to placental damageJ F Clapp, F J Auletta, J Farnham, et al.Journal of Cardiovascular Pharmacology|February 15, 2000
A peripheral site of action for the attenuation of baroflex-mediated bradycardia by intravenous mu-opioid agonistsA T Omoniyi, A Kett, D Wu, et al.Gynecologic and Obstetric Investigation|January 1, 1982
Fetal death in utero: effect on estrone, estradiol-17 beta and progesterone levels in the eweR M Abrams, P S Kalra, J F Clapp, et al.Endocrinology|November 1, 1982
Ovine placental cortisol productionJ F Clapp, N C Thabault, C A Hubel, et al.The Journal of Pharmacology and Experimental Therapeutics|May 1, 1980
Renal tubular secretion of meperidine by the fetal lambH H Szeto, J F Clapp, R W Larrow, et al.Peptides|March 31, 1999
Respiratory depression after intravenous administration of delta-selective opioid peptide analogsH H Szeto, Y Soong, D Wu, et al.American Journal of Obstetrics and Gynecology|June 3, 1998
Baroreflex-mediated bradycardia but not tachycardia is blunted peripherally by intravenous mu-opioid agonistsA Kett, A T Omoniyi, H Kim, et al.Pageof 10